Cleared Traditional

K833137 - ORTHO B-HCG SLIDE TEST FOR PREGNANCY

K833137 is an FDA 510(k) clearance for ORTHO B-HCG SLIDE TEST FOR PREGNANCY, manufactured by Ortho Diagnostic Systems, Inc.. The device is a Class 2 Chemistry device with product code JHJ cleared through the Traditional 510(k) pathway after a 126-day FDA review.

K833137 · Ortho Diagnostic Systems, Inc. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 1984
Decision
126d
Days
Class 2
Risk

K833137 is an FDA 510(k) clearance for the ORTHO B-HCG SLIDE TEST FOR PREGNANCY. Classified as Agglutination Method, Human Chorionic Gonadotropin (product code JHJ), Class II - Special Controls.

Submitted by Ortho Diagnostic Systems, Inc. (Carpinteria, US). The FDA issued a Cleared decision on January 18, 1984 after a review of 126 days - within the typical 510(k) review window.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1155 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Chemistry review framework, consistent with the majority of Class II 510(k) submissions.

View all Ortho Diagnostic Systems, Inc. devices

FDA 510(k) Submission Details - K833137

510(k) Number K833137 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 14, 1983
Decision Date January 18, 1984
Days to Decision 126 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
38d slower than avg
Panel avg: 88d · This submission: 126d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

JHJ Device Classification - Class 2, Special Controls

Product Code JHJ Agglutination Method, Human Chorionic Gonadotropin
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1155
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - JHJ Agglutination Method, Human Chorionic Gonadotropin

All 54
Devices cleared under the same product code (JHJ) and FDA review panel - the closest regulatory comparables to K833137.
B-NEOCEPT 30
K840650 · Organon, Inc. · Apr 1984
BHCG-CHECK
K834346 · Diagnostic Technology, Inc. · Feb 1984
FERTITUBE PREGNANCY TEST #1120
K832867 · Stanbio Laboratory · Feb 1984
QUIDEL HCG ENZYME IMMUNOASSAY KIT
K833156 · Quidel Corp. · Nov 1983
B-SLIDE PREGNATE PREGNANCY TEST KIT
K832879 · Fisher Scientific Co., LLC · Oct 1983
QUICK-TELL INDIRECT PREGNANCY TEST
K832640 · Stanbio Laboratory · Oct 1983